The Biopharma CEO Confidence Index is a forward-looking indicator designed to measure C-suite sentiment and confidence in the biopharma industry’s economy.


The BCI measures c-suite and executive leadership sentiment in the biopharma industry asking questions about their confidence levels concerning key issues. We look for the BCI to become a valuable and highly sought-after resource for its key insights across both key industry-related issues and business functions:

  • Capital Markets
  • Deal Landscape
  • Mergers and Acquisitions
  • Clinical Development
  • Regulatory Affairs
  • Commercialization
  • Business Model and Workforce

Click Here to view the results of the 2020 Q1 BCI Index